CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
10.06
+0.01 (0.05%)
Oct 31, 2024, 4:00 PM EDT - Market closed
CorMedix Market Cap
CorMedix has a market cap or net worth of $580.79 million as of October 31, 2024. Its market cap has increased by 208.93% in one year.
Market Cap
580.79M
Enterprise Value
564.79M
1-Year Change
208.93%
Ranking
Category
Stock Price
$10.06
Market Cap Chart
Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $580.79M, an increase of 1,598.21%. That is a compound annual growth rate of 21.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2024 | 609.80M | 195.88% |
| Dec 29, 2023 | 206.10M | 18.31% |
| Dec 30, 2022 | 174.20M | 0.52% |
| Dec 31, 2021 | 173.30M | -27.40% |
| Dec 31, 2020 | 238.70M | 27.78% |
| Dec 31, 2019 | 186.80M | 37.45% |
| Dec 31, 2018 | 135.90M | 304.46% |
| Dec 29, 2017 | 33.60M | -45.72% |
| Dec 30, 2016 | 61.90M | -13.79% |
| Dec 31, 2015 | 71.80M | 67.76% |
| Dec 31, 2014 | 42.80M | 114.00% |
| Dec 31, 2013 | 20.00M | 143.90% |
| Dec 31, 2012 | 8.20M | 156.25% |
| Dec 30, 2011 | 3.20M | -84.62% |
| Dec 31, 2010 | 20.80M | -39.18% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 608.08M |
| Entrada Therapeutics | 607.86M |
| Savara | 601.62M |
| Acelyrin | 596.85M |
| Third Harmonic Bio | 595.71M |
| Pharming Group | 592.04M |
| Terns Pharmaceuticals | 587.33M |
| Celcuity | 586.19M |